Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

UNITED THERAPEUTICS (UTHR) Other Non Operating Income: 2009-2024

Historic Other Non Operating Income for UNITED THERAPEUTICS (UTHR) over the last 16 years, with Dec 2024 value amounting to $5.8 million.

  • UNITED THERAPEUTICS's Other Non Operating Income rose 5.17% to $6.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$900,000, marking a year-over-year decrease of 111.54%. This contributed to the annual value of $5.8 million for FY2024, which is 141.43% up from last year.
  • Latest data reveals that UNITED THERAPEUTICS reported Other Non Operating Income of $5.8 million as of FY2024, which was up 141.43% from -$14.0 million recorded in FY2023.
  • In the past 5 years, UNITED THERAPEUTICS's Other Non Operating Income ranged from a high of $49.3 million in FY2020 and a low of -$40.2 million during FY2022.
  • Moreover, its 3-year median value for Other Non Operating Income was -$14.0 million (2023), whereas its average is -$16.1 million.
  • As far as peak fluctuations go, UNITED THERAPEUTICS's Other Non Operating Income plummeted by 195.26% in 2022, and later skyrocketed by 141.43% in 2024.
  • UNITED THERAPEUTICS's Other Non Operating Income (Yearly) stood at $49.3 million in 2020, then dropped by 14.40% to $42.2 million in 2021, then crashed by 195.26% to -$40.2 million in 2022, then surged by 65.17% to -$14.0 million in 2023, then surged by 141.43% to $5.8 million in 2024.